Veradigm and Komodo Health Partner to Create the Largest Linked EHR and Claims Dataset for Life Science Research

Komodo Health has entered a long-term strategic partnership with Veradigm, an Allscripts business unit, to advance life sciences research.

Initially, the partnership will focus on linking Allscripts’ ambulatory electronic health records (EHR) data with Komodo’s Healthcare Map, which contains encounter data from more than 150 private and public platforms. Using the Komodo Health platform, the collaboration will allow Veradigm to provide a linked dataset containing a complete longitudinal view of nearly 50 million deidentified patients to support life sciences companies as they investigate new ways to reduce disease burden.

“Data increasingly must be the backbone of every decision and every product in health care—yet stakeholders across the health care ecosystem lack access to an accurate view of patient health, provider practices, and outcomes,” said Komodo Health CEO and co-founder Arif Nathoo, M.D. “Veradigm is changing the game by delivering timely insights from complete patient journeys that will power new technologies and expand the ability of health care stakeholders to demonstrate value.”

The linked dataset combines detailed clinical and patient lifestyle information, along with cost and utilization data captured across all care settings. Veradigm’s model for real-world research is built on access to near real-time patient data, analytics, and point-of-care programs. The partnership with Komodo Health will enable Veradigm to develop and create new and creative real-world evidence solutions for its life sciences customers.

“Komodo has curated one of the largest sources of U.S. health care encounters, which offers not just a comprehensive picture of patient journeys across the health care system, but a broad view of the U.S. insured population,” said Veradigm CEO Tom Langan. “This relationship will enhance our ability to provide a comprehensive understanding of both clinical and economic health outcomes while enabling us to develop new innovative solutions for real-world research.”

Read the original press release here.

See further coverage in Becker’s Hospital Review.